000			02193 a2200673 4500
005			20250517111829.0
264		0	_c20170926
008			201709s 0 0 eng d
022			_a1476-5594
024	7		_a10.1038/onc.2016.283 _2doi
040			_aNLM _beng _cNLM
100	1		_aApicella, M
245	0	0	_aDual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort. _h[electronic resource]
260			_bOncogene _c03 2017
300			_a1200-1210 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged, 80 and over
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCetuximab _xadministration & dosage
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aEsophageal Neoplasms _xdrug therapy
650	0	4	_aEsophagogastric Junction _xdrug effects
650	0	4	_aGene Amplification
650	0	4	_aHumans
650	0	4	_aLapatinib
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred NOD
650	0	4	_aMice, SCID
650	0	4	_aPhosphorylation
650	0	4	_aProto-Oncogene Proteins c-met _xantagonists & inhibitors
650	0	4	_aQuinazolines _xadministration & dosage
650	0	4	_aSignal Transduction
650	0	4	_aStomach Neoplasms _xdrug therapy
650	0	4	_aTumor Cells, Cultured
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aMigliore, C
700	1		_aCapelôa, T
700	1		_aMenegon, S
700	1		_aCargnelutti, M
700	1		_aDegiuli, M
700	1		_aSapino, A
700	1		_aSottile, A
700	1		_aSarotto, I
700	1		_aCasorzo, L
700	1		_aCassoni, P
700	1		_aDe Simone, M
700	1		_aComoglio, P M
700	1		_aMarsoni, S
700	1		_aCorso, S
700	1		_aGiordano, S
773	0		_tOncogene _gvol. 36 _gno. 9 _gp. 1200-1210
856	4	0	_uhttps://doi.org/10.1038/onc.2016.283 _zAvailable from publisher's website
999			_c26327935 _d26327935